These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21492957)

  • 1. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO antigen blood-group compatibility in corneal transplantation.
    Borderie VM; Lopez M; Vedie F; Laroche L
    Cornea; 1997 Jan; 16(1):1-6. PubMed ID: 8985625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
    Coster DJ; Williams KA
    Am J Ophthalmol; 2005 Dec; 140(6):1112-22. PubMed ID: 16376660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corneal transplantation].
    Mellin KB
    Zentralbl Chir; 1992; 117(12):695-700. PubMed ID: 1285478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment.
    Dua HS; Azuara-Blanco A
    Indian J Ophthalmol; 1999 Mar; 47(1):3-9. PubMed ID: 16130277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation.
    Sanfilippo F; MacQueen JM; Vaughn WK; Foulks GN
    N Engl J Med; 1986 Jul; 315(1):29-35. PubMed ID: 3520323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W; Gao H; Xie L; Wang S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplantation Studies.
    Fink N; Stark WJ; Maguire MG; Stulting D; Meyer R; Foulks G; Smith RE; Rapoza P
    Cesk Oftalmol; 1994 Feb; 50(1):3-12. PubMed ID: 8137435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group.
    Arch Ophthalmol; 1992 Oct; 110(10):1392-403. PubMed ID: 1417537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corneal transplantation and histocompatibility of the HLA system].
    Piquot X; Delbosc B; Montard M; Bosc JM; Royer J
    Bull Soc Ophtalmol Fr; 1990; 90(6-7):615-8. PubMed ID: 2225258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunobiology of corneal transplantation.
    Williams KA; Coster DJ
    Transplantation; 2007 Oct; 84(7):806-13. PubMed ID: 17984831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.